Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

09/17/2021 | 04:04pm EDT

DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 2021-09-17 / 22:03 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

The AFM (the Netherlands Authority For the Financial Markets) has informed us on September 15, 2021 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 13 sep 2021 Person obliged to notify: BlackRock, Inc. Issuing institution: Qiagen N.V. Registration Chamber of Commerce: 12036979 Place of residence: VENLO

Distribution in numbers

Type of share       Number of     Number of voting    Capital       Voting      Manner of disposal      Settlement 
                    shares        rights              interest      rights 
Ordinary share      32.909.366,00 35.400.723,00       Real          Real        Indirectly - BlackRock, 
                                                                                Inc. 
Contract for        117.211,00    117.211,00          Potential     Potential   Indirectly - BlackRock, In Cash 
difference                                                                      Inc. 
Ordinary share      749.676,00    749.676,00          Potential     Potential   Indirectly - BlackRock, Physical 
                                                                                Inc.                    Delivery Distribution in percentages 
Type             Total holding Directly real Directly potential Indirectly real Indirectly potential 
Capital interest 14,63 %       0,00 %        0,00 %             14,26 %         0,38 % 
Voting rights    15,71 %       0,00 %        0,00 %             15,34 %         0,38 % 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM: https://www.afm.nl/en/professionals/registers/meldingenregisters/ substantiele-deelnemingen/details?id=115620

-----------------------------------------------------------------------------------------------------------------------

2021-09-17 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

-----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      QIAGEN N.V. 
              Hulsterweg 82 
              5912 PL Venlo 
              Netherlands 
Internet:     www.qiagen.com 
 
End of News   DGAP News Service 
=------------ 

1233599 2021-09-17

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1233599&application_name=news

(END) Dow Jones Newswires

September 17, 2021 16:03 ET (20:03 GMT)

All news about QIAGEN N.V.
10/14QIAGEN N : Redburn Starts Qiagen NV at Buy
MT
10/12QIAGEN N.V. : Release of a capital market information
DJ
10/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
DJ
10/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
10/07QIAGEN NV : NorldLB sticks Neutral
MD
10/07QIAGEN NV : Receives a Buy rating from Deutsche Bank
MD
10/06PRESS RELEASE : BioRiver selects three innovative therapeutic and diagnostic approaches as..
DJ
10/05QIAGEN N.V. : Release of a capital market information
DJ
10/01QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
10/01QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
DJ
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2021 2 155 M - -
Net income 2021 449 M - -
Net Debt 2021 907 M - -
P/E ratio 2021 26,3x
Yield 2021 -
Capitalization 11 717 M 11 717 M -
EV / Sales 2021 5,86x
EV / Sales 2022 6,01x
Nbr of Employees 5 900
Free-Float 98,3%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 51,64 $
Average target price 55,96 $
Spread / Average Target 8,36%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-2.29%11 717
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414